| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |